Exposure–Bleeding Count Modeling of Emicizumab for the Prophylaxis of Bleeding in Persons with Hemophilia A with/Without Inhibitors Against Factor VIII

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1179-1926

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Exposure–Bleeding Count Modeling of Emicizumab for the Prophylaxis of Bleeding in Persons with Hemophilia A with/Without Inhibitors Against Factor VIII ; day:12 ; month:3 ; year:2021 ; pages:1-11
Clinical pharmacokinetics ; (12.3.2021), 1-11

Creator: Jonsson, Fredrik
Schmitt, Christophe
Petry, Claire
Mercier, Francois
Frey, Nicolas
Retout, Sylvie

Contributor: SpringerLink (Online service)

DOI: 10.1007/s40262-021-01006-0

URN: urn:nbn:de:101:1-2021040200225110785795

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:44 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Jonsson, Fredrik
Schmitt, Christophe
Petry, Claire
Mercier, Francois
Frey, Nicolas
Retout, Sylvie
SpringerLink (Online service)

Other Objects (12)

Analysis of Bleeding Frequency in Hemophilia.

Expert Opinion for Defining a Severe Bleeding Phenotype to Guide Prophylaxis in Patients with Nonsevere Hemophilia

Prevention and Management of Bleeding Episodes in Children with Hemophilia

Decreased Bleeding Rates in Patients with Hemophilia A Switching from Standard-Half-Life FVIII to BAY 94-9027 Prophylaxis

Prevention and Management of Bleeding Episodes in Patients with Acquired Hemophilia A

Moroctocog Alfa (AF-CC) for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Patients with Hemophilia A in India

Facial Hematoma: An Atypical Bleeding Site for Acquired Hemophilia

Antithrombin inhibition using nanobodies to correct bleeding in hemophilia

Scurvy with gastrointestinal bleeding

Bleeding management: rFVIIIFc in hemophilia A and liver transplantation

Confronting COVID-19: Issues in Hemophilia and Congenital Bleeding Disorders

Bleeding management: rFVIIIFc in hemophilia A and liver transplantation

Analysis of Bleeding Frequency in Hemophilia.

Expert Opinion for Defining a Severe Bleeding Phenotype to Guide Prophylaxis in Patients with Nonsevere Hemophilia

Prevention and Management of Bleeding Episodes in Children with Hemophilia

Decreased Bleeding Rates in Patients with Hemophilia A Switching from Standard-Half-Life FVIII to BAY 94-9027 Prophylaxis

Prevention and Management of Bleeding Episodes in Patients with Acquired Hemophilia A

Moroctocog Alfa (AF-CC) for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Patients with Hemophilia A in India

Facial Hematoma: An Atypical Bleeding Site for Acquired Hemophilia

Antithrombin inhibition using nanobodies to correct bleeding in hemophilia

Scurvy with gastrointestinal bleeding

Bleeding management: rFVIIIFc in hemophilia A and liver transplantation

Confronting COVID-19: Issues in Hemophilia and Congenital Bleeding Disorders

Bleeding management: rFVIIIFc in hemophilia A and liver transplantation

Analysis of Bleeding Frequency in Hemophilia.

Expert Opinion for Defining a Severe Bleeding Phenotype to Guide Prophylaxis in Patients with Nonsevere Hemophilia

Prevention and Management of Bleeding Episodes in Children with Hemophilia

Decreased Bleeding Rates in Patients with Hemophilia A Switching from Standard-Half-Life FVIII to BAY 94-9027 Prophylaxis

Prevention and Management of Bleeding Episodes in Patients with Acquired Hemophilia A

Moroctocog Alfa (AF-CC) for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Patients with Hemophilia A in India

Facial Hematoma: An Atypical Bleeding Site for Acquired Hemophilia

Antithrombin inhibition using nanobodies to correct bleeding in hemophilia

Scurvy with gastrointestinal bleeding

Bleeding management: rFVIIIFc in hemophilia A and liver transplantation

Confronting COVID-19: Issues in Hemophilia and Congenital Bleeding Disorders

Bleeding management: rFVIIIFc in hemophilia A and liver transplantation

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Exposure–Bleeding Count Modeling of Emicizumab for the Prophylaxis of Bleeding in Persons with Hemophilia A with/Without Inhibitors Against Factor VIII

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Analysis of Bleeding Frequency in Hemophilia.

Expert Opinion for Defining a Severe Bleeding Phenotype to Guide Prophylaxis in Patients with Nonsevere Hemophilia

Prevention and Management of Bleeding Episodes in Children with Hemophilia

Decreased Bleeding Rates in Patients with Hemophilia A Switching from Standard-Half-Life FVIII to BAY 94-9027 Prophylaxis

Prevention and Management of Bleeding Episodes in Patients with Acquired Hemophilia A

Moroctocog Alfa (AF-CC) for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Patients with Hemophilia A in India

Facial Hematoma: An Atypical Bleeding Site for Acquired Hemophilia

Antithrombin inhibition using nanobodies to correct bleeding in hemophilia

Scurvy with gastrointestinal bleeding

Bleeding management: rFVIIIFc in hemophilia A and liver transplantation

Confronting COVID-19: Issues in Hemophilia and Congenital Bleeding Disorders

Bleeding management: rFVIIIFc in hemophilia A and liver transplantation

Analysis of Bleeding Frequency in Hemophilia.

Expert Opinion for Defining a Severe Bleeding Phenotype to Guide Prophylaxis in Patients with Nonsevere Hemophilia

Prevention and Management of Bleeding Episodes in Children with Hemophilia

Decreased Bleeding Rates in Patients with Hemophilia A Switching from Standard-Half-Life FVIII to BAY 94-9027 Prophylaxis

Prevention and Management of Bleeding Episodes in Patients with Acquired Hemophilia A

Moroctocog Alfa (AF-CC) for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Patients with Hemophilia A in India

Facial Hematoma: An Atypical Bleeding Site for Acquired Hemophilia

Antithrombin inhibition using nanobodies to correct bleeding in hemophilia

Scurvy with gastrointestinal bleeding

Bleeding management: rFVIIIFc in hemophilia A and liver transplantation

Confronting COVID-19: Issues in Hemophilia and Congenital Bleeding Disorders

Bleeding management: rFVIIIFc in hemophilia A and liver transplantation

Analysis of Bleeding Frequency in Hemophilia.

Expert Opinion for Defining a Severe Bleeding Phenotype to Guide Prophylaxis in Patients with Nonsevere Hemophilia

Prevention and Management of Bleeding Episodes in Children with Hemophilia

Decreased Bleeding Rates in Patients with Hemophilia A Switching from Standard-Half-Life FVIII to BAY 94-9027 Prophylaxis

Prevention and Management of Bleeding Episodes in Patients with Acquired Hemophilia A

Moroctocog Alfa (AF-CC) for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Patients with Hemophilia A in India

Facial Hematoma: An Atypical Bleeding Site for Acquired Hemophilia

Antithrombin inhibition using nanobodies to correct bleeding in hemophilia

Scurvy with gastrointestinal bleeding

Bleeding management: rFVIIIFc in hemophilia A and liver transplantation

Confronting COVID-19: Issues in Hemophilia and Congenital Bleeding Disorders

Bleeding management: rFVIIIFc in hemophilia A and liver transplantation

Related objects

Reset password